Results 231 to 240 of about 1,616,867 (388)

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery.

open access: yesNew England Journal of Medicine, 1994
M. O’connell   +8 more
semanticscholar   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

NITROPRUSSIDE INFUSIONS

open access: yesBritish Journal of Anaesthesia, 1983
G G, Graham, D, Rigg
openaire   +2 more sources

Physiological response to long-term peripheral and central leptin infusion in lean and obese mice.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1997
J. Halaas   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy